Accuray has recently declared that it has signed a multi-year master research and collaboration agreement with Rotterdam, a Netherlands-based Erasmus Medical Center (MC). Through this partnership on advanced research in radiation oncology, Accuray and Erasmus MC will promote treatment technology and innovative medical tools that will enable healthcare experts to provide better treatment.
Since the 2004 installation of its first CyberKnife Robotic Radiosurgery System, Accuray has been working with Erasmus MC on research initiatives, enabling Erasmus to be the fourth site in the Europe India Middle East and Africa (EIMEA) region to have its centre installed with CyberKnife System. So far, Erasmus MC has used CyberKnife System to treat over 1,000 patients. Additionally, Erasmus conducted a clinical research on the extensive application of the CyberKnife System. It has served as author for several book chapters and over 20 technical and clinical publications in peer-reviewed journals. Based on innovative research methods, the center has carried out evaluation on the CyberKnife System’s performance, such as dose calculation accuracy assessments, assessment of the impact of intra-fraction patient motion on clinical tracking accuracy, Synchrony Respiratory Tracking System-based clinical tracking accuracy of lung treatments, and methods for minimal treatment time. At present, the center is assessing hypothetical path sets and also evaluates the InTempo Adaptive Imaging System that improves the CyberKnife System’s capability in consistent tracking and rectifying of prostate movement during treatment.
During the last quarter, Accuray reported two additional research and collaboration agreements with two Heidelberg-based luminary research institutions, including the German Cancer Research Center, and the University of Heidelberg.